Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

Kim Margolin(University of Washington), Marc S. Ernstoff(Dartmouth–Hitchcock Medical Center), Omid Hamid(Angeles Clinic and Research Institute), Donald P. Lawrence(Massachusetts General Hospital), David F. McDermott(Beth Israel Deaconess Medical Center), Igor Puzanov(Vanderbilt University Medical Center), Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center), Joseph I. Clark(Loyola University Chicago), Mario Sznol(Yale Cancer Center), Theodore F. Logan(Indiana University – Purdue University Indianapolis), Jon Richards(Oncology Specialists), Tracy Michener(Bristol-Myers Squibb (Germany)), Ágnes Balogh(Bristol-Myers Squibb (Belgium)), Kevin N. Heller(Bristol-Myers Squibb (United States)), F. Stephen Hodi(Dana-Farber Cancer Institute)
The Lancet Oncology
March 26, 2012
Cited by 1,081

Abstract


Related Papers

No related papers found

Powered by citation graph analysis